Figlin, R A <br/><br/>
Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  02 2018 
 - 324-331 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdx743  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Renal Cell--drug therapy<br/>Chemotherapy, Adjuvant--methods<br/>Disease-Free Survival<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Molecular Targeted Therapy--methods<br/>Neoplasm Recurrence, Local--pathology<br/>Patient Selection<br/>Risk Factors<br/>Treatment Outcome